Agnieszka earned her PhD at the Wrocław University of Science and Technology, where she discovered a JHBP gene promoter sequence and analyzed elements regulating its expression. During this time, she also worked at the Department of Clinical Immunology IITE PAS in Wrocław, where she developed and implemented assays for the diagnosis and monitoring of patients with myeloproliferative disorders, and who were undergoing blood transplants. Since 2009, Agnieszka has continued her scientific career at the University of Wrocław, focusing her research activities on changes in gene expression patterns that are related to carbohydrate metabolism in cells undergoing neoplastic transformations and in cells related to neurodegenerative disorders. In parallel, Agnieszka also completed postgraduate studies in research project management at the Adam Mickiewicz University in Poznan.
Meet our team
Pure Biologics comprises a team of extremely talented and energetic people who pursue their goals with passion. Our team consists of employees with broad competences and extensive experience gained in research units from around the world.
Robert obtained his doctorate at the Wroclaw University of Science and Technology, where he investigated protein folding processes. After his doctorate, Robert worked at the Adam Mickiewicz University in Poznan, University of Helsinki (Finland) and the University of Leeds (England). He then further expanded his knowledge and experience in cloning, expression, purification as well as protein modification and analysis at the EMBL in Hamburg, BESSY in Berlin (Germany), University Hospital in Lund (Sweden) and the ESRF in Grenoble (France). He has participated in several projects related to production and structural analysis of proteins. He is a co-author of the project on commercial use of protein lattices in structural research. He is an awardee of the Pol-Postdoc II competition and was a member of the Crystallographic Committee of the Polish Academy of Sciences from 2007-2010.
Originally from the USA, David began his career in protein chemistry by obtaining a B.Sc. in Biochemistry at San Francisco State University (USA). In Montréal (Canada) he then earned an M.Sc. in Biochemistry at Concordia University and his Ph.D. in Microbiology at McGill University. During this time, he focused heavily on using biophysical technologies to investigate protein-small molecule and protein-protein interactions alike. This led him to Berlin (Germany), where he performed postdoctoral research at the Max Delbrück Center for Molecular Medicine (MDC). At the MDC he obtained an MDC-GoBio Fellowship, allowing him to screen chemical libraries and to discover small molecule inhibitors of human lysine demethylase enzymes. During this time, he used X-ray crystallography and complementary biophysical technologies to further develop inhibitors for entry into preclinical testing programs.
Jakub is a graduate of biotechnology from the Jagiellonian University. During his undergraduate studies he completed several international research internships (IGMM-Montpellier, CNIC-Madrid, A.I. Virtanen Institute-Kuopio). Jakub then relocated to Montpellier (France) for doctoral studies, where he discovered new functions of Twist oncogenes, demonstrating their protective properties during oxidative and hypoxic stress. He then continued research in the field of oxidative stress and its influence on mitotic arrest at the University of Dundee (UK). Throughout his research projects, Jakub gained general knowledge in the field of molecular and cell biology, developing particular expertise in the design of cell-based assays, production of viral vectors, gene expression analysis and live cell imaging.
Anna, is a microbiologist-geneticist, a graduate of the Faculty of Biological Sciences at the University of Wrocław. While still a graduate student, she completed an internship at the Catholic University of Louvain (Belgium), where she expanded her knowledge and skills in molecular biology and genetic engineering. During her doctorate, she studied the terpenoid pathway in flax and developed an effective method of epigenetic modulation of genetic activity in plants. At the same time, she was involved in several R&D projects and activities of the Linum Foundation for the therapeutic application of flax products. After graduation, she gained experience in clinical trials as their coordinator. The acquired skills are reflected in the certificates, incl. real-time PCR techniques, laboratory quality management system (ISO/IEC 17025:2005) and clinical research.
Tomasz is a graduate of the Jagiellonian University in Kraków, where his training in research was supported by a START scholarship from the Foundation for Polish Science. Since 2011, he has focused on leveraging hybridoma and phage display technologies to discover new antibodies. Tomasz has also attained expertise in antibody engineering, in designing their effector functions, and in improving antibody stability. His work has contributed to the development of both diagnostic and therapeutic biomolecules alike and has led to four patents. Tomasz also discovered a new mechanism of post-translational proteolytic processing of mouse IgM and has elucidated structural determinants of mouse IgG3 oligomerization.
Chiranjeevi earned his doctorate at University of Göttingen (Germany). During his doctoral studies he focused on studying synaptopathies in autism spectrum diseases using in vivo models. He continued his further research in stem cells at Vrije Universiteit Brussel (Belgium) as a post-doctoral researcher funded by Belgian federal grant – BELSPO. Next, he received an independent DFF-MOBILEX mobility research grant and Marie Curie program stipend, and continued his research in Aarhus University (Denmark) and later in Oxford University (UK). During this time, he investigated encephalopathy and glioblastoma diseases upon viral infections and consecutive immunological response applying various in vivo and in vitro models.
Ewelina is a graduate of biotechnology at the University of Silesia in Katowice and she defended her doctorate at the Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences in Wrocław. During her studies, she investigated the processes related to programmed cell death, in particular the participation of Bcl-2 proteins in programmed death of cancer cells and the interactions between apoptosis, necrosis, and autophagy in cells under oxidative stress. After her doctorate, she worked in pharmaceutical and medical device companies, where she was responsible for planning and implementing R&D projects, product development and clinical evaluation of medical devices. Ewelina successfully planned and coordinated the course and publication of the results of a medical experiment with the participation of patients, in which the operation of an innovative medical device for telemedicine was evaluated.
Niina obtained her doctorate at Karolinska Institute in Sweden in tumor biology. After post-doctoral studies, she worked at several biotech companies, like: Bioinvent International, Alligator Bioscience (Sweden) and Molecular Partners (Swtitzerland), mainly focusing on immuno-oncology and preclinical drug development. During her career, Niina has headed several departments and have taken part in the development of multiple I/O assets, like: BI-505, Mitazalizumab, ATOR-1015, ATOR-1017, ALG.APV-527, MP0310, MP0317, and MP420. Niina is a co-inventor and co-author of several patents and publications. After her last position in a start-up company in Belgium, Niina has focused on consultancy of preclinical drug development.
Michał Piróg is a graduate from the University of Wroclaw, where he received his Ph.D. in the field of molecular physiology. During his graduate studies, he focused on embryology, specializing in developmental biology, genetics and cell physiology. Michał then worked as a scientist in Scotland, and later as an embryologist at a fertility clinic in Poland. For six years he was an embryology laboratory manager and a person responsible for keeping and archiving medical records. Proof of Michał’s knowledge and skills are supported by numerous certificates, such as an ISO 9001:2015 audit management diploma and an ESHRE Senior Clinical Embryologist certificate – the highest certificate in the field of human embryology.
Maciej Mazurek has been associated with the company since its foundation. He is a molecular biologist by training and has also finished “Executive MBA” studies at the Polish-American School of Business. Maciej has a dozen years of experience gained in Poland, as well as abroad (at the Medical College of Georgia, USA, and at Imperial College London, UK), taking part in several R&D projects, both as a researcher and as a project manager. He is an author of two patents and one patent-pending application. Maciej specializes in developing ideas, in acquiring public funds, and in monitoring business environments.
Kinga is a microbiologist and geneticist, having completed her Ph.D. at the Institute of Immunology and Experimental Therapy of Polish Academy of Sciences. She broaden her scientific experience during a post-doctoral fellowship at the Institute for Molecular Biology in Houston (USA) and at the Wrocław University of Environmental and Life Sciences. Kinga is also a qualified executive, having a Polish-American MBA from Franklin University (Ohio, USA) and WSB University in Wrocław. Kinga also holds a certificate in PRINCE2 project management. Since 2010, she has managed both science and business projects. Between 2009 and 2013 she cooperated with the Wrocław Research Center EIT+, where she executed her original project – “Humanitarium” Science Center.
Martyna is a graduate of the Faculty of Biological Sciences at the University of Wrocław and Executive MBA studies at the Polish-American School of Business. She joined Pure Biologics in 2015. She participated in processes related to the transformation of the company, its entry into the NewConnect market and its transition to the main market of the Warsaw Stock Exchange. She is responsible for the company’s bodies management and contacts with investors, while actively supporting the company’s finance area.
Michał Surma worked on his doctorate at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden (Germany) and at the University of California in San Francisco (USA). Cell biology, lipids and lipidomics are his major specialties, but he is also knowledgeable in laboratory operations, high-throughput projects, QM, GLP and other biotech-related activities. In 2012, Michał, along with professor Kai Simons and colleagues, commercialized their lipidomic analysis technology and started a biotech company – Lipotype GmbH, where Michał was Head of Analytical Services, responsible for commercial operations and customer service. Later on, he worked at the Łukasiewicz Research Network – PORT Polish Center for Technology Development as Core Facilities Leader, coordinating the work of six laboratories.
After completing her undergraduate studies in philology, Marta Rot pursued postgradute education in Labour Law and Social Law at the Faculty of Law, Administration and Economics at the of University of Wrocław. During this time, she also completed the Human Resources Management course at the Wrocław University of Economics. She is a certified business coach, a consultant on organizational efficiency, an Assessment & Development Center assessor, and a manager with more than 20 years of experience in HR. Marta gained her expertise at large corporate structures (Telefonia Dialog, Netia), and at a research & development institution operating in the area of bio- and nanotechnology. She is a lecturer of postgraduate courses for HR Business Partners at Wrocław University of Economics and she holds ongoing collaborations with the WSB University in Wrocław, the University of Wroclaw, and the Wrocław University of Science and Technology.
Aldona Pietraszek is a graduate of the Faculty of Physics and Astronomy at the University of Wrocław, where she obtained a master’s degree in medical physics. Since 2009, she has run her own training center, and starting from 2015 she has been the office manager. She worked for Polish and foreign companies dealing with architecture, IT and logistics. She has experience in both European and Asian work cultures.
A graduate of the University of Wroclaw. He completed postgraduate studies in project management. Since 2010, IT administrator, particularly interested in network engineering, MCTNA, MCTRE, MCTSWE, UWEA. He cooperated with many companies as an external consultant, project manager for IT implementations and IT administrator.